A detailed history of Veriti Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Veriti Management LLC holds 1,213 shares of BIIB stock, worth $210,807. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,213
Previous 2,746 55.83%
Holding current value
$210,807
Previous $636,000 63.05%
% of portfolio
0.01%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$189.07 - $236.8 $289,844 - $363,014
-1,533 Reduced 55.83%
1,213 $235,000
Q2 2024

Aug 02, 2024

BUY
$190.52 - $236.72 $191,663 - $238,140
1,006 Added 57.82%
2,746 $636,000
Q1 2024

Apr 19, 2024

SELL
$212.02 - $267.71 $21,414 - $27,038
-101 Reduced 5.49%
1,740 $375,000
Q4 2023

Feb 05, 2024

BUY
$222.59 - $267.94 $37,172 - $44,745
167 Added 9.98%
1,841 $476,000
Q3 2023

Oct 27, 2023

SELL
$253.3 - $285.89 $63,325 - $71,472
-250 Reduced 12.99%
1,674 $430,000
Q2 2023

Jul 13, 2023

BUY
$275.25 - $318.06 $40,186 - $46,436
146 Added 8.21%
1,924 $548,000
Q1 2023

Apr 26, 2023

BUY
$256.56 - $292.34 $4,618 - $5,262
18 Added 1.02%
1,778 $494,000
Q4 2022

Jan 20, 2023

BUY
$252.44 - $306.72 $97,946 - $119,007
388 Added 28.28%
1,760 $0
Q3 2022

Oct 26, 2022

BUY
$194.69 - $268.46 $22,194 - $30,604
114 Added 9.06%
1,372 $366,000
Q2 2022

Jul 18, 2022

BUY
$187.54 - $223.02 $5,813 - $6,913
31 Added 2.53%
1,258 $257,000
Q1 2022

Apr 11, 2022

BUY
$193.77 - $244.14 $19,377 - $24,414
100 Added 8.87%
1,227 $258,000
Q4 2021

Jan 19, 2022

SELL
$223.92 - $287.77 $26,646 - $34,244
-119 Reduced 9.55%
1,127 $270,000
Q3 2021

Oct 08, 2021

BUY
$282.99 - $369.05 $56,598 - $73,810
200 Added 19.12%
1,246 $353,000
Q2 2021

Jul 13, 2021

SELL
$259.0 - $414.71 $120,176 - $192,425
-464 Reduced 30.73%
1,046 $362,000
Q1 2021

Apr 14, 2021

BUY
$242.95 - $284.63 $30,611 - $35,863
126 Added 9.1%
1,510 $422,000
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $326,983 - $492,191
1,384 New
1,384 $339,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.